Net profit of Jubilant Pharmova declined 44.60% to Rs 55.90 crore in the quarter ended December 2025 as against Rs 100.90 crore during the previous quarter ended December 2024. Sales rose 16.67% to Rs 2116.10 crore in the quarter ended December 2025 as against Rs 1813.70 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 2116.10 | 1813.70 | 17 |
| OPM % | 13.68 | 15.83 | - |
| PBDT | 253.80 | 240.70 | 5 |
| PBT | 133.10 | 149.40 | -11 |
| NP | 55.90 | 100.90 | -45 |